Conversely, our results suggest that loss of AR signaling derepresses CERK and leads to the elevation of C1P, which could counteract the therapeutic effect of AR antagonists and uncover a mechanism for the development of castration-resistant PCa. This evidence concerns the gene CERK and posterior cortical atrophy.